Oncology News, Insights, Stories by OncoDaily

Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC
2024-12-19 18:00 - 19:00 (America/Halifax)
Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024 by SPCC will be held at December 19, 2024.
This live webinar will start with an introduction by Nadia Harbeck from Germany, setting the stage for the evening’s discussions. Shani Paluch-Shimon from Israel will then present the latest updates on Early Breast Cancer (EBC) from the 2024 San Antonio Breast Cancer Symposium, covering key advancements and findings. Following this, Fatima Cardoso from Portugal will provide insights into the updates on Advanced Breast Cancer (ABC) presented at the same symposium, highlighting new developments and treatments in this area.
After the presentations, there will be a 20-minute discussion and Q&A session where participants can engage with the speakers and ask questions. The event will conclude with closing remarks from Nadia Harbeck, summarizing the key points and takeaways from the session.
For more information about the 2024 San Antonio Breast Cancer Symposium, visit here.

LATAM Course II: Immunotherapy in Lung Cancer by IASLC
2024-12-19 16:00 - 17:00 (America/Halifax)
LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th, 2024.
The exclusive course on the latest updates in lung cancer treatment in LATAM, with a special focus on immunotherapy, will take place in Series II. Renowned thoracic oncology experts from the region will explore the role of immunotherapy in revolutionizing lung cancer care. The discussions will cover crucial topics, including the integration of biomarkers for immunotherapy, optimal management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy will transform the landscape of lung cancer treatment in LATAM, offering hope for improved patient outcomes.
See the Speakers and Series II LATAM Team Below:

LATAM Course II: Immunotherapy in Lung Cancer by IASLC
2024-12-19 16:00 - 17:00 (America/Halifax)
LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19, 2024.
This exclusive Live Course on the latest updates in lung cancer treatment, specifically focusing on immunotherapy, offers a deep dive into the transformative impact of immunotherapy on lung cancer care in Latin America (LATAM). In Series II of the course, leading thoracic oncology experts from the region will lead discussions on pivotal aspects of immunotherapy in lung cancer treatment.
Key topics will include the integration of biomarkers for immunotherapy, which play a critical role in selecting the right patients and optimizing treatment efficacy. Experts will also explore best management strategies for advanced lung cancer, addressing the evolving landscape of treatment options, and discuss specific challenges faced in clinical practice, such as the management of pneumonitis, a common side effect associated with immunotherapy.
The Link for Registration.
See the Speakers and Series II LATAM Team Below:

Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC
2024-12-18 18:00 - 19:00 (America/Halifax)
Haemato-oncology highlights from 66th ASH Annual Meeting by SPCC will be held at December 18, 2024.
This live webinar serves as a crucial platform for oncologists to stay informed about the latest research and breakthroughs in haemato-oncology, with key highlights from the ASH meeting. By providing insights into recent advancements, the webinar aims to deepen participants’ understanding, enhance their education, and promote best practices in haematology, ultimately contributing to improved patient care in the field.
The webinar will begin with an introduction by Jakob Passweg from Switzerland. David Gomez-Almaguer from Mexico will then present the latest highlights in stem cell transplantation and leukemia. Following that, Phillip Scheinberg from Brazil will provide key updates on bone marrow failure. After the presentations, there will be a discussion and Q&A session. The event will conclude with closing remarks by Jakob Passweg.
For more information about, the 66th ASH Annual Meeting visit here.
See the Speakers of this event below:

Jakob Passweg

David Gomez-Almaguer

Phillip Scheinberg

Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC
2024-12-17 18:00 - 19:00 (America/Halifax)
Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 by SPCC will be held at December 17th, 2024.
Join this Live Webinar on advancements in gastrointestinal (GI) cancer care, featuring experts Van Cutsem Eric, Neuzillet Cindy, and Ruiz-Garcia Erika. The event will explore recent breakthroughs in minimally invasive surgery, targeted therapies, and immunotherapy, which are improving survival rates. The speakers will discuss how molecular insights are driving personalized treatment and transforming patient outcomes. Don’t miss this opportunity to learn about the latest developments and future directions in GI cancer care.
The webinar will begin with an introduction by Eric Van Cutsem (BE), setting the stage for the discussions on the latest advancements in immuno-oncology for gastrointestinal cancers. Cindy Neuzillet (FR) will then present on the progress of immuno-oncology in biliary and pancreatic cancers, highlighting the most recent breakthroughs and clinical developments in these challenging and often difficult-to-treat cancers. Following this, Erika Ruiz Garcia (MX) will focus on the advances in immuno-oncology for colorectal and stomach cancer, exploring how emerging therapies are improving outcomes for patients with these common malignancies.
After the presentations, there will be an open discussion and Q&A session, where attendees can engage directly with the speakers, ask questions, and share insights. The webinar will conclude with closing remarks from Eric Van Cutsem (BE), summarizing the key points discussed and providing a forward-looking perspective on the future of immuno-oncology in GI cancer care. This session promises to be an informative and interactive opportunity for healthcare professionals and researchers to learn about the latest advancements in this rapidly evolving field.
Link to register and access the session.

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC
2024-12-16 19:00 - 21:00 (Asia/Shanghai)
SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.
This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.
See the Speakers and Southeast Asia Team Below:

ESMO Immuno-Oncology Congress 2024
2024-12-11 08:00 - 2024-12-13 16:00 (Europe/Helsinki) | Palexpo exhibition centre, 30 Route François-Peyrot , Geneva, 1218, Switzerland
Join the ESMO Immuno-Oncology Congress 2024, happening in Palexpo exhibition Centre in Geneva, Switzerland, and online on 11-13 December. This international event features a comprehensive educational program and highlights the latest scientific advancements in the rapidly evolving field of immunotherapy. It is organized by the European Society for Medical Oncology.
Whether you’re looking to grasp the fundamentals of immunotherapies or delve into cutting-edge research, this congress will address a wide range of topics—from treatment options to managing toxicities and interpreting new data. It’s designed to meet the diverse needs of all oncology stakeholders.
Don’t miss this opportunity to learn, share your research, and connect with leaders who are shaping the future of cancer treatment. Find the registration link here.
More information featuring ESMO at OncoDaily.com.

3rd APHOG Global Seminar 2024
2024-12-11 06:00 - 08:00 (America/Halifax)
3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 is a Virtual Event that will be held at December 11. 2024.
The 3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 focuses on “Soft Tissue Sarcoma: Asian Challenge.” This event aims to address the growing concern of soft tissue sarcomas (STS) in pediatric oncology across Asia. Experts and healthcare professionals from various countries will come together to discuss the latest advancements in the diagnosis, treatment, and management of soft tissue sarcomas in children and adolescents. The seminar will feature presentations on clinical research, emerging therapies, and the unique challenges faced by Asian countries in combating this rare and complex cancer. Additionally, the event will emphasize the importance of collaboration and knowledge exchange to improve outcomes and provide better care for pediatric sarcoma patients in the region.
For Registration Visit Here.

NCI Cancer Integrative Medicine Grantee Virtual Conference
2024-12-10 09:30 - 2024-12-11 15:30 (America/Halifax)
NCI Cancer Integrative Medicine Grantee Virtual Conference will be held from December 10-11, 2024.

This open-to-the-public event, with registration required, will focus on the integration of conventional cancer treatments with complementary therapies to improve patient outcomes and quality of life.
The conference aims to achieve two main objectives:

Grantsmanship: It will provide valuable learning opportunities regarding grantsmanship, tools, and resources from NCI/NIH, while also allowing NCI program staff to hear directly from grantees about their needs and challenges.
Research: The event will showcase NCI/NIH-funded research on cancer-related complementary and integrative medicine. It will highlight key findings and identify gaps or needs for advancing translational and clinical research in integrative oncology, especially in advancing precision medicine across the cancer continuum.

The conference will play a crucial role in advancing the understanding and practice of integrative oncology, which combines standard cancer therapies with complementary methods such as acupuncture, herbal medicine, lifestyle changes, and mind-body techniques. The goal is to enhance both the physical and emotional well-being of cancer patients, improving overall therapeutic outcomes.

Registration is Open.

The San Antonio Breast Cancer Symposium (SABCS) 2024
2024-12-10 00:00 - 2024-12-13 19:00 (America/Halifax) | Henry B. Gonzalez Convention Center in San Antonio, 900 E Market St, San Antonio, San Antonio, TX, 78205-2784
The San Antonio Breast Cancer Symposium (SABCS) 2024 is scheduled to take place from December 10 to December 13, 2024, at San Antonio, Texas.
The event will focus on the latest advancements in breast cancer research and treatments. SABCS 2024 will be available both in-person and virtually, providing flexible options for attendees to engage with the program. The 2024 SABCS will have new sessions offering the latest in breast cancer science and research.
For registration visit here

IOWG Grand Rounds - A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch
2024-12-08 15:00 - 17:00 (Pacific/Easter)
IOWG Grand Rounds – A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch will be held at December 8th, 2024.
It is a Live Webinar will feature expert presentations from Dr. Ting Bao, Dr. Heather Greenlee, and Kathleen Sanders, who will provide valuable perspectives on integrating complementary therapies with traditional cancer treatments. Their work focuses on improving patient outcomes by addressing the whole person—body, mind, and spirit—through a combination of evidence-based medicine and holistic approaches.
In this insightful discussion, the speakers will explore the origins and development of integrative oncology programs at two major U.S. cancer centers: the Zakim Center at Dana-Farber Cancer Institute and the Integrative Medicine Program at Fred Hutchinson Cancer Center. They will share behind-the-scenes stories on how these pioneering centers were established, highlighting the challenges and successes in building comprehensive integrative oncology services. The session will also delve into specific initiatives like Dr. Ting Bao’s role in setting up the Physician Consult Service at Dana-Farber, the development of the MyZakim website, and Fred Hutch’s “Cook for Your Life” website, which provides cancer patients with essential nutrition resources.

The webinar will discuss the Dietary Supplement Review program at Fred Hutch, ensuring patient safety while incorporating supplements into cancer care. Attendees will gain valuable insights into the history and evolution of these programs, learning practical strategies that have enhanced patient care through integrative approaches. This session will showcase how these institutions have shaped the field of integrative oncology and continue to improve the quality of life for cancer patients through innovation and patient-centered care.
The ones who join will have the opportunity to learn about the cutting-edge practices implemented at Dana-Farber and Fred Hutchinson, explore how digital resources can enhance patient care, and gain practical tools to integrate these strategies into their own practice. This is an unmissable event for healthcare providers interested in advancing integrative oncology and improving the overall care and quality of life for cancer patients.

Visit the link for Registration.

The 66th ASH Annual Meeting and Exposition
2024-12-07 00:00 - 2024-12-10 00:00 (America/Halifax) | The Marriott Marquis San Diego Marina, 333 W Harbor Dr, San Diego, San Diego, 92101, United States
The 66th ASH Annual Meeting and Exposition will take place from December 7-10, 2024, in San Diego, California, and online.
The ASH annual meeting is the world’s largest and most comprehensive hematology event of the year. With hundreds of sessions on the hottest trends in hematology, ASH offers multiple ways for attendees to find exactly what they are looking for. Education Program sessions consist of didactic presentations followed by panel discussions and a question-and-answer period with all of the speakers. Mark your calendars now to attend the world’s most comprehensive hematology event of the year.
For registration visit here

ESMO Asia Congress 2024
2024-12-06 10:00 - 2024-12-08 16:00 (Asia/Shanghai) | Suntec Singapore Convention & Exhibition Centre, 1 Raffles Boulevard, Suntec City, 039593, Singapore
The ESMO Asia Congress 2024 will be held at the Suntec Singapore Convention & Exhibition Centre, Singapore, on December 6-8. It is organized by the European Society for Medical Oncology.
This key event brings together oncologists, researchers, and healthcare professionals from Asia and beyond to share the latest in cancer research, clinical trials, and treatment strategies.
Attendees can look forward to a range of scientific sessions covering key topics in oncology, including new research findings and innovative treatment approaches. There will also be educational sessions aimed at providing practical insights that participants can apply in their everyday practice.
Don’t miss this opportunity to connect with peers and shape the future of cancer care in the region!
Register here.
Find more information featuring the Congress at OncoDaily.com.

Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily
2024-12-06 00:00 - 2024-12-08 00:00 (America/Halifax)
Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily will be held from December 6-8, 2024.
We are honored to invite you to the inaugural event of the Global Cancer Movement, an initiative by OncoDaily, aimed at advancing global collaboration in cancer research, treatment, and advocacy.
This three-day virtual event will bring together a diverse range of experts, including leading oncologists, researchers, patients, advocates, and key figures from international health organizations. Together, they will explore the current state of colorectal cancer, addressing both the challenges and opportunities in the fight against this prevalent disease. The event will provide a platform for engaging discussions on the latest scientific research, breakthrough therapies, and global health strategies aimed at improving patient outcomes. It will also focus on how to stimulate innovation in colorectal cancer care, enhance early detection, and ensure equitable access to treatment for all patients. Participants will have the opportunity to collaborate, share knowledge, and shape the future of colorectal cancer treatment and advocacy.
Register here as we strive to create a meaningful impact and drive progress in this critical area of oncology.

The AORTIC PALOP VI Conference
2024-12-05 00:00 - 2024-12-07 00:00 (America/Halifax) | Hospital Cardeal Dom Alexandro Do Nascimento, Luanda, Palanca, Luanda, Angola
The AORTIC PALOP VI Conference will be held from 5-7 December, 2024 at Luanda, Angola.
The AORTIC PALOP VI Conference focuses on advancing cancer research and care in Portuguese-speaking African countries (PALOP). Organized by the African Organisation for Research and Training in Cancer (AORTIC), the event brings together healthcare professionals, researchers, and policymakers to discuss cancer prevention, diagnosis, and treatment. It addresses the unique challenges faced by PALOP nations, such as limited resources and access to care, while promoting collaboration and knowledge-sharing to improve cancer outcomes. The conference aims to strengthen healthcare systems and enhance research efforts to combat cancer in these regions.
Registration to Attend the In-Person Meeting is free and Here is the Link.

NFCR Global Summit 2025
2024-12-04 08:00 - 17:00 (America/Halifax) | Washington, DC, Washington, United States
NFCR Global Summit and Award Ceremonies For Cancer Research and Entrepreneurship will be held at October 24, 2025.
The Asian Fund for Cancer Research, National Foundation for Cancer Research, and AIM-HI Accelerator Fund are co-hosting a dynamic event that will spotlight groundbreaking cancer research discoveries and the transformative impact of oncology innovation. This content-rich event will feature key programs such as New Frontiers in Cancer Research, the Women’s Leadership and Entrepreneurship Award Ceremony, the Innovative Oncology Company Showcase, and the Szent-Györgyi Prize Award Ceremony.
Taking place live in Washington, DC, USA, the event will bring together a diverse audience, including cancer research donors, patients, academic and industry professionals, and members of the public interested in learning about the latest advancements in cancer research and the cutting-edge products and tools that are revolutionizing cancer treatment. Attendees will have the opportunity to engage with leading experts and innovators, gaining valuable insights into the future of cancer care.

NCCIH 25th Anniversary Celebration
2024-12-02 13:00 - 16:30 (America/New_York) | Lipsett Amphitheater, Building 10, NIH Campus, 9000 Rockville Pike, Bethesda, Maryland, Bethesda, Maryland, MD, United States
The National Center for Complementary and Integrative Health (NCCIH) will celebrate its 25th anniversary by hosting a half-day symposium titled “Exploring the Impact of Whole Person Health” on Monday, December 2, 2024 at Bethesda, Maryland or Virtually.
The event will feature the prestigious Stephen E. Straus Distinguished Lecture in the Science of Complementary Therapies, delivered by Patricia M. Herman, N.D., Ph.D. The lecture is titled “The Economic Impact of Whole Person Health,” offering valuable insights into the economic aspects of integrative and holistic health approaches.
NCCIH 25th Anniversary Celebration will include two important sessions: “The Potential Clinical Impact of Whole Person Health,” which will explore how whole person health care can transform clinical practice, and “The Challenges and Promise of Whole Person Health Research,” which will examine the current obstacles and future possibilities for advancing research in this field. The event is aimed at researchers, clinicians, policymakers, and the general public, providing a platform to share knowledge and ideas.
A reception will follow the symposium, offering an opportunity for networking and further discussion. Interested attendees are encouraged to register to secure their participation in this significant event.

Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC
2024-11-27 18:00 - 19:30 (America/Halifax)
Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27, 2024.
It is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss the de-escalation and escalation of surgery, radiotherapy, and adjuvant treatments. Stephen Johnston from the UK will focus on personalizing adjuvant endocrine therapy, exploring current perspectives and future directions. Following the talks, there will be a 10-minute discussion and Q&A session, allowing participants to engage with the speakers.
The event will conclude with closing remarks by Fiorita Poulakaki, summarizing the key takeaways.

European Cancer Summit 2024
2024-11-20 09:00 - 2024-11-21 18:30 (Europe/Brussels) | Radisson Collection Hotel Brussels, 47 Rue du Fossé Aux Loups, Brussels, Brussels, 1000, Belgium
The European Cancer Summit 2024 will once again unite the cancer community in accelerating efforts against a most relentless disease. Experts, patients and policymakers will explore new innovative solutions to pressing challenges faced by healthcare systems across Europe and propose new opportunities in cancer research.
This year’s European Cancer Summit takes place on 20 & 21 November, in Brussels & online.

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
2024-11-15 00:00 - 2024-11-17 00:00 (Europe/Helsinki) | Espace Saint-Martin, 199 Bis r St Martin, 75003 Paris, Paris, 75001, Sweden
The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024.
It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children, with a particular focus on emerging principles and innovative treatment strategies.
As is customary for ESH, the event will prioritize accessible interactions between young researchers and established experts, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical, translational, and basic research is maintained throughout the conference.
For Registration Visit Here

The 2024 China Conference on Integrative Oncology
2024-11-14 12:00 - 2024-11-17 12:00 (America/Halifax) | Xi’an, China, Xi'an, 710000, China
The 2024 China Conference on Integrative Oncology will be held from November 14-17, 2024 at Xi’an, China.
Organized by the China Anti-Cancer Association, Xijing Hospital of the Air Force Medical University, and others, the conference is expected to draw over 40,000 domestic and 20,000 international participants. Under the theme “Cancer Prevention and Treatment, Winning in Integration,” the event will feature three main sections: “conference,” “exhibition,” and “production,” encompassing academic exchanges, achievement showcases, and industrial collaboration. Oncology professionals are encouraged to submit papers and actively participate in this important event.

2024 Latin America Conference on Lung Cancer
2024-11-14 08:00 - 2024-11-16 16:30 (America/New_York) | Grand Hyatt Bogotá, Cl. 24a #57 – 60, Bogota, Colombia
The IASLC Latin America Conference on Lung Cancer (LALCA24) will be held at the Grand Hyatt Bogotá in Bogotá, Colombia on November 14-16.
LALCA is a vibrant conference with a rich history that will showcase the latest research, a variety of relevant topics, and educational sessions led by top experts.
This event offers an excellent chance to connect with professionals from different fields who are dedicated to thoracic cancers, while also gaining insights into the newest advancements in prevention, detection, and treatment through innovative data presentations.
The event is organized by the International Association for the Study of Lung Cancer (IASCL).
For more information featuring LALCA24 visit OncoDaily.com.

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow
2024-11-13 00:00 - 2024-11-15 00:00 (America/Halifax) | New York Hilton Midtown, Grand Ballroom (Located on the 3 rd Floor) 1335 Avenue of the Americas, New York, 10019, United States
42nd Annual CFS: Innovative Cancer Therapy for Tomorrow will be held from November 13-15, 2024 at New York, USA.

Entering its 42nd year, the Chemotherapy Foundation Symposium (CFS) remains a premier event that brings together thousands of healthcare professionals for a dynamic 3-day conference focused on delivering cutting-edge, evidence-based cancer care. Esteemed faculty from around the world will share their expertise on the latest developments in cancer therapeutics, providing attendees with a unique opportunity to explore how new and innovative approaches can be integrated into current treatment paradigms to improve care for cancer patients.
With ongoing rapid progress in the management of solid and hematologic malignancies, the past year has seen significant shifts in practice, with new diagnostic, therapeutic, and supportive care strategies being implemented. At CFS, participants will gain critical insights into optimized treatments, including chemotherapies, targeted therapies, immunotherapies, and multimodal approaches that are shaping the future of oncology care.

London Global Cancer Week 2024
2024-11-11 08:30 - 2024-11-15 22:00 UTC | The Royal Marsden Education and Conference Centre, Fulham Road London SW3 6JJ, London, United Kingdom
London Global Cancer Week 2024 will be held from November 11-15, 2024 at London, UK.
In 2016, the Royal Society of Medicine Oncology Section initiated annual one-day meetings aimed at improving global cancer outcomes. This evolved into London Global Cancer Week in 2019, expanding the format to a week-long series of multidisciplinary meetings that address the global challenges of cancer. Since its launch, London Global Cancer Week has grown annually, and in 2024, it will feature more presentations and speakers than ever before.
London Global Cancer Week will feature a diverse series of events hosted by experts committed to improving global cancer outcomes showcasing innovative solutions and progress in cancer control initiatives fostering coherent policymaking through holistic discussions acting as a catalyst for positive change benefiting individuals and families affected by cancer with no charge for organizations to present or attendees to participate.
For programme of the event, visit here.

15th ESO-EONS Masterclass in Oncology Nursing
2024-11-08 20:30 - 2024-11-12 13:00 (Europe/Helsinki) | San Servolo, San Servolo, 20100, Italy
15th ESO-EONS Masterclass in Oncology Nursing will be held on San Servolo (Venice), Italy from November 8-11, 2024.
The ESO Masterclass in Oncology Nursing is an intensive programme for European cancer nurses, offering three and a half days of immersive oncology education. It focuses on enhancing clinical skills, improving patient care, and advancing clinical leadership.
Nursing sessions will cover key areas such as patient assessment, safety, communication, symptom management, and nursing research. Case studies presented by participants will explore specialized care practices.
Joint sessions with physicians emphasize the need for interdisciplinary collaboration in cancer care, while practical training in case studies will focus on essential skills for patient care management.
Deadline for applications: Friday 24 May 2024

Frontiers in gynaecological oncology
2024-11-07 09:00 - 2024-11-08 00:00 (Europe/Helsinki) | Pristina, Kosovo, Pristina, 10000
Frontiers in gynaecological oncology will be held at Pristina, Kosovo from November 7-8, 2024.
The European School of Oncology offers support to Clinical Institutes through its Visiting Professorship Meeting (VPM) initiative. This program is designed for renowned clinical oncology centers whose medical teams are interested in participating in internal educational meetings conducted in English.

16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
2024-11-07 08:00 - 2024-11-10 17:00 (Europe/Helsinki) | Lisbon Congress Centre, Praça das Indústrias 1, Lisbon, 1300-307, Portugal
16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon, Portugal, from 7 to 10 November 2024.
Top experts in medical oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology gathered at the EMUC24 congress from 7 to 10 November 2024 to share insights on best practices, major trial developments, and breakthroughs.
The scientific programme featured in-depth lectures, practical hands-on courses, and dynamic multidisciplinary case discussions. EMUC24 highlighted cutting-edge therapies, current practices, controversies, and emerging technologies in GU cancer treatment.
This multidisciplinary approach was achieved through collaboration with the European Society for Medical Oncology (ESMO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Association of Urology (EAU), alongside contributions from the Kidney Cancer Association (KCA) on recent kidney cancer advancements.

4th APHOG & SIOP Asia Joint Scientific Symposium 2024 on Retinoblastoma
2024-11-06 07:00 - 21:00 (America/Halifax)
The 4th APHOG & SIOP Asia Joint Scientific Symposium 2024 will focus on the topic of Retinoblastoma. This event will take place via Zoom on Wednesday, November 6, 2024. The session will be held from 07:00 to 09:00 EST (USA), 16:30 to 18:30 IST (India), and 20:00 to 22:00 JST (Japan).
The organizers of the event are the Asian Continental Branch International Society of Pediatric Oncology (SIOP Asia) and the Asian Pediatric Hematology and Oncology Group (APHOG). For more information about the agenda, check the flyer.
Join this important symposium, where experts from across the region will share insights and advancements in research and treatment. Don’t miss this opportunity to engage in meaningful discussions and expand your knowledge on this critical topic!
Make sure to register here.
Find more information featuring SIOP Asia at OncoDaily.

Lung cancer highlights from the ESMO Congress 2024 by SPCC
2024-11-05 18:00 (America/Halifax)
Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th, 2024.
It is a live webinar by SPCC which will be futuring Aleksandra Filipovic, Alfredo Addeo, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies, including targeted treatments, immunotherapies, and innovative surgical techniques, are now available, having a profound and positive impact on patients’ lives by improving outcomes and quality of care. However, with the fast-paced development and the vast amount of clinical data being generated from ongoing research and presented at international conferences, it can be challenging for clinicians and healthcare professionals to stay up to date with the latest evidence and treatment options.
For registration visit here

ESH 4th How to Diagnose and Treat Lymphoma
2024-11-01 08:30 - 2024-11-03 12:30 (Europe/Helsinki) | Hotel Clarion, Ringvägen 98, Stockholm, 10460, Sweden
ESH 4th How to Diagnose and Treat Lymphoma will be held from November 1-3, 2024 at Stockholm, Sweden.
ESH (European School of Haematology)’s ‘How to Diagnose and Treat’ meetings are specialized, disease-specific events designed to provide in-depth insights into the latest advances in diagnostics and clinical management of various hematological conditions. These meetings focus on the presentation and analysis of real-life clinical cases, offering attendees a practical, case-based learning experience.
Interactive voting technology is incorporated as a self-assessment tool, enabling participants to evaluate their understanding while fostering increased scientific engagement and discussion. Through this approach, ESH promotes a dynamic exchange of ideas between experts and clinicians, helping to advance best practices in patient care.
For more information and registration visit here
